{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T18:45:19Z","timestamp":1791139519979,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1016\/j.jaad.2003.12.031","type":"journal-article","created":{"date-parts":[[2004,7,8]],"date-time":"2004-07-08T11:14:16Z","timestamp":1089285256000},"page":"52-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":179,"title":["Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines"],"prefix":"10.1016","volume":"51","author":[{"given":"Pearl E","family":"Grimes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Avaniss-Aghajani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Soriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Meraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Metzger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2003.12.031_BIB1","series-title":"2 Dermatology. WebMD Scientific American (r) Medicine","first-page":"526","article-title":"XV Disorders of pigmentation","author":"Grimes","year":"2003"},{"key":"10.1016\/j.jaad.2003.12.031_BIB2","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0738-081X(97)00126-0","article-title":"Immune mechanisms in vitiligo","volume":"15","author":"Bystryn","year":"1997","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaad.2003.12.031_BIB3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0733-8635(05)70416-2","article-title":"Recent investigations on vitiligo vulgaris","volume":"15","author":"Nordlund","year":"1997","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2003.12.031_BIB4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0002-9343(71)90232-4","article-title":"On the etiology of vitiligo and gray hair","volume":"51","author":"Lerner","year":"1971","journal-title":"Am J Med"},{"key":"10.1016\/j.jaad.2003.12.031_BIB5","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1365-2133.1994.tb08486.x","article-title":"Neuropeptide and neuronal marker studies in vitiligo","volume":"131","author":"Al'Abadie","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2003.12.031_BIB6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0738-081X(89)90063-1","article-title":"Serum antibodies in vitiligo patients","volume":"7","author":"Bystryn","year":"1989","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaad.2003.12.031_BIB7","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0738-081X(97)00125-9","article-title":"Pathophysiology of vitiligo","volume":"15","author":"Castanet","year":"1997","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaad.2003.12.031_BIB8","first-page":"534","article-title":"The effects of isoprinosine treatment on repigmentation and immunologic aberrations in vitiligo","volume":"98","author":"Grimes","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2003.12.031_BIB9","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1034\/j.1600-0749.2003.00023.x","article-title":"Evidence for an autoimmune pathogenesis of vitiligo","volume":"16","author":"Ongenae","year":"2003","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.jaad.2003.12.031_BIB10","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/1523-1747.ep12289743","article-title":"Alterations in IL-6, IL-8, GM-CSF, TNF-\u03b1, and IFN-\u03b3 release by peripheral mononuclear cells in patients with active vitiligo","volume":"108","author":"Yu","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2003.12.031_BIB11","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1346-8138.1997.tb02292.x","article-title":"Relationship between levels of soluble interleukin-2 receptors and the types of activity of vitiligo","volume":"24","author":"Honda","year":"1997","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2003.12.031_BIB12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0923-1811(99)00029-8","article-title":"Levels of soluble interleukin-2 receptor in the sera and skin tissue fluids of patients with vitiligo","volume":"21","author":"Caixia","year":"1999","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaad.2003.12.031_BIB13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1034\/j.1600-0749.2002.1o049.x","article-title":"New insights into the pathogenesis of vitiligo","volume":"15","author":"Moretti","year":"2002","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.jaad.2003.12.031_BIB14","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1365-4362.1994.tb02903.x","article-title":"Effect of prolonged treatment with levamisole on vitiligo with limited and slow-spreading disease","volume":"33","author":"Pasricha","year":"1994","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2003.12.031_BIB15","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-4362.1989.tb02517.x","article-title":"Vitiligo repigmentation with Anapsos (Polypodium leucotomos)","volume":"28","author":"Mohammad","year":"1989","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2003.12.031_BIB16","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1346-8138.1998.tb02391.x","article-title":"Suplatast tosilate (IPD), a new immunoregulator, is effective in vitiligo treatment","volume":"25","author":"Nihei","year":"1998","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2003.12.031_BIB17","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1067\/mjd.2002.126250","article-title":"Topical tacrolimus for repigmentation of vitiligo","volume":"47","author":"Grimes","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2003.12.031_BIB18","first-page":"158","article-title":"Tacrolimus ointment 0.1% produces repigmentation in patients with vitiligo","volume":"71","author":"Tanghetti","year":"2003","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2003.12.031_BIB19","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1001\/archderm.139.5.581","article-title":"A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo","volume":"139","author":"Lepe","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2003.12.031_BIB20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1034\/j.1600-0781.2003.00005.x","article-title":"Repigmentation of chronic vitiligo lesions by following tacrolimus plus ultraviolet-B-narrow-band","volume":"19","author":"Castanedo-Cazares","year":"2003","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.jaad.2003.12.031_BIB21","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0167-5699(92)90111-J","article-title":"The mechanism of action of cyclosporin A and FK506","volume":"13","author":"Schreiber","year":"1992","journal-title":"Immunol Today"},{"key":"10.1016\/j.jaad.2003.12.031_BIB22","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0733-8635(18)30271-7","article-title":"Vitiligo","volume":"11","author":"Grimes","year":"1993","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2003.12.031_BIB23","first-page":"21","article-title":"Therapeutic trends for the treatment of vitiligo","volume":"15","author":"Grimes","year":"2002","journal-title":"Cosmetic Dermatol"},{"key":"10.1016\/j.jaad.2003.12.031_BIB24","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1067\/mjd.2001.109812","article-title":"Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children","volume":"44","author":"Kang","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2003.12.031_BIB25","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1067\/mjd.2001.109813","article-title":"A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients","volume":"44","author":"Paller","year":"2001","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2003.12.031_BIB26","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1067\/mjd.2001.109817","article-title":"Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part II, safety","volume":"44","author":"Soter","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2003.12.031_BIB27","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1523-1747.1998.00323.x","article-title":"Tacrolimus ointment does not ancect collagen synthesis results of a single-center randomized trial","volume":"111","author":"Reitamo","year":"1998","journal-title":"J Invest Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.jaad.2003.12.031_BIB28","first-page":"S247","article-title":"Long-term safety and efficacy of tacrolimus ointment monotherapy in atopic dermatitis patients: open-label study results","volume":"129","author":"Paller","year":"2002","journal-title":"Ann Dermatol Venereol"},{"issue":"Suppl 1","key":"10.1016\/j.jaad.2003.12.031_BIB29","first-page":"S415","article-title":"Safety and efficacy of tacrolimus ointment monotherapy in over 7900 atopic dermatitis patients: results of an open-label study","volume":"129","author":"Koo","year":"2002","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.jaad.2003.12.031_BIB30","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/jid.1965.131","article-title":"Melanocyte populations in UV-irradiated human skin","volume":"45","author":"Quevedo","year":"1965","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2003.12.031_BIB31","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/1523-1747.ep12258559","article-title":"Mitotic activity of epidermal melanocytes in UV-irradiated mouse skin","volume":"70","author":"Rosdahl","year":"1978","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2003.12.031_BIB32","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/1523-1747.ep12505758","article-title":"New melanogenesis and photobiological processes in activation and proliferation of precursor melanocytes after UV-exposure ultrastructural differentiation of precursor melanocytes from Langerhans cells","volume":"78","author":"Jimbow","year":"1982","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2003.12.031_BIB33","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/1523-1747.ep12598343","article-title":"The induction of melanogenesis by ultraviolet light in the pigmentary system of Rhesus monkeys","volume":"65","author":"Erickson","year":"1975","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2003.12.031_BIB34","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/jcp.1041330111","article-title":"Ultraviolet radiation directly induces pigment production by cultured human melanocytes","volume":"133","author":"Friedmann","year":"1987","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.jaad.2003.12.031_BIB35","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/jid.1959.37","article-title":"The melanocyte cytology and cytochemistry","volume":"32","author":"Fitzpatrick","year":"1959","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2003.12.031_BIB36","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/1523-1747.ep12514597","article-title":"PUVA-induced repigmentation of vitiligo scanning electron microscopy of hair follicles","volume":"74","author":"Ortonne","year":"1980","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2003.12.031_BIB37","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/1523-1747.ep12480997","article-title":"Role of hair follicles in the repigmentation of vitiligo","volume":"97","author":"Cui","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2003.12.031_BIB38","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0140-6736(73)93256-X","article-title":"Risk of cancer in renal transplant recipients","volume":"2","author":"Hoover","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2003.12.031_BIB39","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/BF02574501","article-title":"Malignancy after renal transplantation incidence and role of type of immunosuppression","volume":"9","author":"Tremblay","year":"2002","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jaad.2003.12.031_BIB40","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/00007890-199609150-00009","article-title":"A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue, Study Group","volume":"62","author":"Woodle","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.jaad.2003.12.031_BIB41","series-title":"Protopic (tacrolimus) ointment full prescribing information","year":"2000"},{"key":"10.1016\/j.jaad.2003.12.031_BIB42","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/1523-1747.ep12460991","article-title":"Interleukins 1\u03b1 and 6 and tumor necrosis factor-\u03b1 are paracrine inhibitors of human melanocyte proliferation and melanogenesis","volume":"96","author":"Swope","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2003.12.031_BIB43","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/1523-1747.ep12478093","article-title":"Modulation of melanocyte intercellular adhesion molecule-1 by immune cytokines","volume":"90","author":"Yohn","year":"1990","journal-title":"J Invest Dermatol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2003.12.031_BIB44","doi-asserted-by":"crossref","first-page":"191S","DOI":"10.1038\/jid.1993.75","article-title":"Influence of inflammatory mediators and cytokines on human melanocyte function","volume":"100","author":"Morelli","year":"1993","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2003.12.031_BIB45","doi-asserted-by":"crossref","first-page":"619","DOI":"10.7326\/0003-4819-113-8-619","article-title":"The soluble interleukin-2 receptor biology, function, and clinical application","volume":"13","author":"Rubin","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2003.12.031_BIB46","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1600-0625.1993.tb00023.x","article-title":"Review of the etiopathomechanism of vitiligo: a convergence theory","volume":"2","author":"Le Poole","year":"1993","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaad.2003.12.031_BIB47","first-page":"74","article-title":"Tacrolimus (FK506)","volume":"5","author":"Lawrence","year":"1988","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2003.12.031_BIB48","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1016\/S0091-6749(99)70051-5","article-title":"Pathogenesis of atopic dermatitis","volume":"104","author":"Leung","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2003.12.031_BIB49","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0190-9622(86)70085-6","article-title":"Abberations in T lymphocytes and natural killer cells in vitiligo a flow cytometric study","volume":"14","author":"Halder","year":"1986","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2003.12.031_BIB50","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-4362.1992.tb03946.x","article-title":"Nonsegmental vitiligo","volume":"31","author":"Abdel-Naser","year":"1992","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2003.12.031_BIB51","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0190-9622(96)90490-9","article-title":"Cytomegalovirus DNA identified in skin biopsy specimens of patients with vitiligo","volume":"35","author":"Grimes","year":"1996","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962204005171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962204005171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T21:34:58Z","timestamp":1759268098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962204005171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["S0190962204005171"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2003.12.031","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2003.12.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}